tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Catalyst Pharmaceuticals Inc

CPRX
Add to Watchlist
31.490USD
0.0000.00%
Close 07-14 16:00（ET）Quotes delayed by 15 min
3.85BMarket Cap
17.43P/E TTM

Catalyst Pharmaceuticals Inc

31.490
0.0000.00%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

CPRX Financials

See Catalyst Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Catalyst Pharmaceuticals Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
0.52/0.46
Revenue / Forecast
149.39M/148.17M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
588.99M
19.78%
EPS(YoY)
1.75
26.68%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
11.61%0.52
-8.10%0.43
16.68%0.43
23.57%0.43
134.41%0.47
42.88%0.47
227.82%0.37
-2.87%0.35
-28.86%0.20
34.08%0.33
---0.29
--0.36
--0.28
--0.24
----
----
----
----
----
----
Revenue
5.63%149.39M
7.61%152.61M
15.31%148.39M
19.44%146.56M
43.56%141.42M
28.26%141.82M
25.33%128.69M
23.23%122.71M
15.40%98.51M
81.98%110.57M
79.39%102.69M
87.49%99.58M
98.12%85.37M
58.60%60.76M
59.21%57.24M
46.06%53.11M
42.66%43.09M
23.52%38.31M
22.64%35.95M
22.83%36.37M
Net Profit
12.33%63.73M
-5.79%52.70M
20.28%52.78M
27.73%52.11M
143.77%56.74M
60.53%55.94M
242.65%43.88M
8.03%40.79M
-21.28%23.27M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
173.62%25.47M
120.23%22.75M
77.48%21.62M
72.79%13.24M
-18.61%9.31M
-76.17%10.33M
24.55%12.18M
Net Margin
6.34%42.66%
-12.45%34.53%
4.31%35.57%
6.95%35.55%
69.80%40.12%
25.16%39.44%
213.82%34.10%
-12.33%33.24%
-31.79%23.63%
-24.83%31.51%
---29.96%
--37.92%
--34.64%
--41.92%
----
----
----
----
----
----
Gross Margin
3.83%83.82%
-1.84%76.71%
0.87%78.44%
-0.34%79.56%
3.76%80.73%
0.83%78.15%
-0.23%77.76%
0.57%79.83%
-3.59%77.81%
-4.98%77.51%
--77.94%
--79.38%
--80.70%
--81.57%
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
Income Statement
Revenue
5.63%149.39M
7.61%152.61M
15.31%148.39M
19.44%146.56M
43.56%141.42M
28.26%141.82M
25.33%128.69M
23.23%122.71M
15.40%98.51M
81.98%110.57M
79.39%102.69M
87.49%99.58M
98.12%85.37M
58.60%60.76M
59.21%57.24M
46.06%53.11M
42.66%43.09M
23.52%38.31M
22.64%35.95M
22.83%36.37M
Operating profit
15.57%73.23M
-1.59%61.85M
30.17%66.27M
22.22%66.30M
133.60%63.37M
50.73%62.84M
236.90%50.91M
16.16%54.25M
-23.82%27.13M
35.36%41.69M
-248.15%-37.19M
63.46%46.70M
105.05%35.61M
141.73%30.80M
79.25%25.10M
80.38%28.57M
77.19%17.37M
47.86%12.74M
19.65%14.00M
54.04%15.84M
Net Profit
12.33%63.73M
-5.79%52.70M
20.28%52.78M
27.73%52.11M
143.77%56.74M
60.53%55.94M
242.65%43.88M
8.03%40.79M
-21.28%23.27M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
173.62%25.47M
120.23%22.75M
77.48%21.62M
72.79%13.24M
-18.61%9.31M
-76.17%10.33M
24.55%12.18M
Balance Sheet
Current assets
37.14%940.39M
43.36%894.03M
58.16%852.45M
59.93%758.74M
69.48%685.72M
184.33%623.61M
180.70%539.00M
96.88%474.43M
103.41%404.60M
-31.63%219.33M
-30.51%192.02M
-0.66%240.97M
-10.07%198.91M
52.68%320.80M
43.32%276.31M
37.58%242.56M
36.93%221.19M
31.94%210.11M
34.50%192.79M
34.42%176.31M
Total current liabilities
18.58%132.40M
21.94%147.15M
22.15%128.74M
22.41%113.01M
40.32%111.65M
58.66%120.68M
82.33%105.39M
75.83%92.32M
40.31%79.57M
32.08%76.06M
29.37%57.81M
133.47%52.50M
147.23%56.71M
112.79%57.59M
116.75%44.68M
39.37%22.49M
58.89%22.94M
18.93%27.06M
13.07%20.61M
-20.16%16.14M
Total assets
26.27%1.15B
29.66%1.10B
36.22%1.05B
37.59%971.91M
40.55%908.87M
81.11%851.41M
86.83%772.01M
59.13%706.36M
58.80%646.68M
25.15%470.11M
24.04%413.21M
66.06%443.90M
64.89%407.23M
57.97%375.63M
49.21%333.11M
27.82%267.31M
25.23%246.97M
23.62%237.79M
27.67%223.25M
59.14%209.13M
Total liabilities
17.74%134.91M
20.95%149.71M
18.27%131.36M
18.61%115.89M
34.39%114.59M
50.52%123.78M
71.77%111.07M
42.42%97.70M
15.90%85.26M
9.34%82.23M
2.52%64.66M
161.67%68.60M
175.00%73.57M
142.95%75.21M
156.53%63.07M
29.88%26.22M
44.09%26.75M
36.04%30.96M
34.86%24.59M
-0.12%20.19M
Total equity
27.50%1.01B
31.15%954.27M
39.23%920.25M
40.64%856.03M
41.48%794.28M
87.59%727.63M
89.63%660.94M
62.18%608.65M
68.26%561.41M
29.11%387.88M
29.07%348.55M
55.66%375.29M
51.51%333.66M
45.25%300.42M
35.93%270.04M
27.60%241.09M
23.27%220.22M
21.95%206.83M
26.84%198.66M
69.91%188.94M
Cash Flow Statement
Net operating income
-0.76%59.59M
-36.66%44.89M
-55.49%32.44M
11.17%71.30M
88.08%60.04M
27.37%70.88M
61.48%72.87M
108.54%64.14M
164.50%31.93M
38.85%55.65M
9.27%45.13M
17.42%30.75M
42.37%12.07M
109.00%40.08M
90.27%41.30M
67.09%26.19M
122.29%8.48M
46.32%19.18M
89.56%21.71M
18.17%15.68M
Net investment
---27.00K
63.64%-32.00K
100.00%0.00
-160.00%-26.00K
100.00%0.00
99.77%-88.00K
99.72%-259.00K
---10.00K
99.88%-199.00K
---38.32M
-70215.91%-92.82M
-100.00%0.00
---162.37M
100.00%0.00
-94.12%-132.00K
333.47%9.34M
100.00%0.00
---41.00K
99.32%-68.00K
---4.00M
Net financing
-520.65%-12.87M
-677.04%-25.58M
177.90%4.65M
-24.63%872.00K
-97.83%3.06M
766.62%4.43M
41.01%-5.97M
640.65%1.16M
94563.76%141.05M
-129.52%-665.00K
-354.19%-10.13M
92.85%-214.00K
109.61%149.00K
189.19%2.25M
289.90%3.98M
19.29%-2.99M
-925.00%-1.55M
-9979.15%-2.53M
-441.69%-2.10M
-10340.05%-3.71M

FAQs

What is the total revenue of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 588.99M, with a year-on-year change of 491.73M.

What are the current assets of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its current assets were 894.03M, with a year-on-year change of 43.36.

What are the total assets of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its total assets of Catalyst Pharmaceuticals Inc were 1.10B, with a year-on-year change of 29.66.

What are the total liabilities of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Catalyst Pharmaceuticals Inc were 149.71M, with a year-on-year change of 20.95.

What is the total equity of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its total equity of Catalyst Pharmaceuticals Inc was 954.27M, with a year-on-year change of 31.15.

What is the net operating income of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Catalyst Pharmaceuticals Inc was 257.78M, with a year-on-year change of 32.11.

What is the net investment of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its net investment of Catalyst Pharmaceuticals Inc was -58.00K, with a year-on-year change of 89.57.

What is the net financing of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its net financing of Catalyst Pharmaceuticals Inc was -16.99M, with a year-on-year change of -112.08.

What is the Earnings Per Share (EPS) of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.75, with a year-on-year change of 26.68.

What is the net income of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its net income was 214.33M, with a year-on-year change of 30.78.

What is the net margin of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 36.39, with a year-on-year change of 9.18.

What is the gross margin of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 78.82, with a year-on-year change of 0.54.

What is the Return on Equity (ROE) of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 25.49, with a year-on-year change of -13.26.

What is the Return on Assets (ROA) of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 21.92, with a year-on-year change of -11.62.

What is the operating profit of Catalyst Pharmaceuticals Inc?

According to Catalyst Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 257.78M, with a year-on-year change of 32.11.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy